Search Results - "Cheung, Edna"

Kinetically stabilized inflation by Li, Changhong, Gong, Hao, Cheung, Yeuk-kwan Edna

“…A bstract In this work, we propose a string-inspired two fields inflation model to address the fine-tuning problem that the standard inflation model suffers…”
Get full text

TALE activators regulate gene expression in a position- and strand-dependent manner in mammalian cells by Uhde-Stone, Claudia, Cheung, Edna, Lu, Biao

“…•TAL effectors (TALEs) are a class of customizable transcription factors.•We used dual reporters to study the effects of TALE binding site location.•We found…”
Get full text

Transcriptional regulation of FoxO3 gene by glucocorticoids in murine myotubes by Kuo, Taiyi, Liu, Patty H, Chen, Tzu-Chieh, Lee, Rebecca A, New, Jenny, Zhang, Danyun, Lei, Cassandra, Chau, Andy, Tang, Yicheng, Cheung, Edna, Wang, Jen-Chywan

“…Glucocorticoids and FoxO3 exert similar metabolic effects in skeletal muscle. FoxO3 gene expression was increased by dexamethasone (Dex), a synthetic…”
Get more information

The leukemia strikes back: a review of pathogenesis and treatment of secondary AML by Cheung, Edna, Perissinotti, Anthony J., Bixby, Dale L., Burke, Patrick W., Pettit, Kristen M., Benitez, Lydia L., Brown, Julia, Scappaticci, Gianni B., Marini, Bernard L.

Get full text

Big Bounce Genesis and Possible Experimental Tests: A Brief Review by Cheung, Yeuk-Kwan, Li, Changhong, Vergados, Joannis

“…We review the recent status of big bounce genesis as a new possibility of using dark matter particles' mass and interaction cross-section to test the existence…”
Get full text

The CST bounce universe model — A parametric study by Cheung, Yeuk-Kwan Edna, Song, Xue, Li, ShuYi, Li, YunXuan, Zhu, YiQing

“…A bounce universe model with a scale-invariant and stable spectrum of primordial density perturbations was constructed using a consistent truncation of the…”
Get full text

Impact of Race on Bortezomib-Induced Peripheral Neuropathy by Cheung, Edna, Pang, Katherine

“…Introduction: A key dose-limiting toxicity of bortezomib is peripheral neuropathy, which is managed by prompt dose reduction or discontinuation. However, the…”
Get full text

Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen with Methotrexate-Based GvHD Prophylaxis by On, Sandy, Domingo, Walter, Cheung, Edna, Johnston, Laura

“…Introduction: Reduced-intensity conditioning (RIC) allogeneic stem cell transplant (allo-SCT) remains a curative option for elderly and/or unfit patients with…”
Get full text

Immune-related adverse effects of long-term PD-1/PD-L1 inhibtor treatment by Kim, Sarah, Colevas, A. Dimitrios, Tse, Stephanie, On, Sandy, Cheung, Edna

“…2661 Background: Immune-related adverse effects (irAE) are autoimmune-like toxicities caused by immune checkpoint inhibitor (ICI) treatment and often…”
Get full text

Cladribine and Low-Dose Cytarabine-Based Salvage Therapy for Relapsed/Refractory AML in a Predominantly Venetoclax-Exposed Cohort by Cheung, Edna, Schumann, Claire, Zhang, Tian Y., Fakhri, Bita, Gotlib, Jason, Liedtke, Michaela, Shomali, William, Mannis, Gabriel

“…Introduction: Relapsed/refractory acute myeloid leukemia (R/R AML) remains challenging to treat. Unfit patients receive either targeted therapy for actionable…”
Get full text

Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation by On, Sandy, Domingo, Walter, Cheung, Edna, Johnston, Laura

“…Fludarabine makes up the cornerstone of reduced-intensity conditioning (RIC) regimens for allogeneic stem cell transplant (alloHCT). However, during the…”
Get full text

Access, Interest, and Attitudes Toward Electronic Communication for Health Care Among Patients in the Medical Safety Net by Schickedanz, Adam, Huang, David, Lopez, Andrea, Cheung, Edna, Lyles, C. R., Bodenheimer, Tom, Sarkar, Urmimala

“…ABSTRACT BACKGROUND Electronic and internet-based tools for patient–provider communication are becoming the standard of care, but disparities exist in their…”
Get full text

Outcomes with Molecularly Targeted Agents As Salvage Therapy Following Frontline HMA/Venetoclax in Adults with Acute Myeloid Leukemia: A Multi-Center Retrospective Analysis by Khanna, Vishesh, Azenkot, Tali, Liu, Selina (Qiuying), Gilbert, Jason, Cheung, Edna, Lau, Kimberly, Pollyea, Daniel A., Traer, Elie, Jonas, Brian A., Zhang, Tian Y., Mannis, Gabriel N.

Get full text

The limitations of today’s clinical guidance: Atypical femoral fracture and long-term bone-modifying agents in the oncology setting by Cheung, Edna, Borno, Hala T

“…While bone-modifying agents such as bisphosphonates and denosumab are crucial to preventing skeletal-related events in patients with bone metastases, the…”
Get full text

Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent by On, Sandy, Rath, Carolyn G., Lan, Michelle, Wu, Bobby, Lau, Kimberly M., Cheung, Edna, Alegria, William, Young, Rebecca, Tan, Marisela, Kim, Carrie, Phun, Jennifer, Patel, Nimish, Mannis, Gabriel, Logan, Aaron C., Kennedy, Vanessa, Goodman, Aaron, Taplitz, Randy A., Young, Patricia A., Wen, Raymond, Saunders, Ila M.

“…Summary We investigated the incidence of invasive fungal infections (IFIs) and other infectious complications in patients receiving venetoclax and…”
Get full text

Routine Use of Gemtuzumab Ozogamicin in 7+3-Based Inductions for All “Non-Adverse” Risk AML by Hui, Gavin, Ladha, Abdullah, Cheung, Edna, Berube, Caroline, Coutre, Steven, Gotlib, Jason, Liedtke, Michaela, Zhang, Tian Y, Muffly, Lori S., Mannis, Gabriel N.

“…Introduction: The addition of gemtuzumab ozogamicin (GO) to 7+3 chemotherapy for newly diagnosed acute myeloid leukemia (AML) has been shown to significantly…”
Get full text

Kinetically stabilized inflation by Li, Changhong, Gong, Hao, Cheung, Yeuk-kwan Edna

“…In this work, we propose a string-inspired two fields inflation model to address the fine-tuning problem that the standard inflation model suffers. The…”
Get full text

Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis by Khanna, Vishesh, Azenkot, Tali, Liu, Selina (Qiuying), Gilbert, Jason, Cheung, Edna, Lau, Kimberly, Pollyea, Daniel A., Traer, Elie, Jonas, Brian A., Zhang, Tian Y., Mannis, Gabriel N.

Get full text

The leukemia strikes back: a review of pathogenesis and treatment of secondary AML by Cheung, Edna, Perissinotti, Anthony J., Bixby, Dale L., Burke, Patrick W., Pettit, Kristen M., Benitez, Lydia L., Brown, Julia, Scappaticci, Gianni B., Marini, Bernard L.

“…Secondary AML is associated with a disproportionately poor prognosis, consistently shown to exhibit inferior response rates, event-free survival, and overall…”
Get full text

Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML by Ladha, Abdullah, Hui, Gavin, Cheung, Edna, Berube, Caroline, Coutre, Steven E., Gotlib, Jason, Liedtke, Michaela, Zhang, Tian Y., Muffly, Lori, Mannis, Gabriel N.

Get full text